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Abstract 20 
Collagens, the most abundant proteins in animals, also occur in some recently described 21 
nucleocytoplasmic large DNA viruses such as Mimiviridae, which replicate in amoebae. To 22 
clarify the impact of viral collagens on the immune response of animals exposed to 23 
Mimiviridae, we have investigated the localization of collagens in Acanthamoeba polyphaga 24 
mimivirus particles and the response of mice to immunization with mimivirus particles. 25 
Using protein biotinylation, we have first shown that viral collagen encoded by the ORF L71 26 
is present at the surface of mimivirus particles. Exposure to mimivirus collagens elicited the 27 
production of anti-collagen antibodies in DBA/1 mice immunized intra-dermally with 28 
mimivirus protein extracts. This antibody response also targeted mouse collagen type II and 29 
was accompanied by T-cell reactivity to collagen and joint inflammation as observed in 30 
collagen-induced arthritis following immunization of mice with bovine collagen type II. The 31 
broad distribution of nucleocytoplasmic large DNA viruses in the environment suggests that 32 
humans are constantly exposed to such large virus particles. A survey of blood sera from 33 
human healthy subjects and from rheumatoid arthritis patients indeed demonstrated that 34 
30% of healthy subject and 36% of rheumatoid arthritis sera recognized the major 35 
mimivirus capsid protein L425. Moreover, whereas 6% of healthy subject sera recognized 36 
the mimivirus collagen protein L71, 22% of rheumatoid arthritis sera were positive for 37 
mimivirus L71. Accordingly, our study shows that environmental exposure to mimivirus 38 
represents a risk factor in triggering autoimmunity to collagens.    39 
  40 
3 
 
Introduction 41 
Nucleocytoplasmic large DNA viruses (NCLDVs) represent a growing group of giant viruses 42 
found in various types of aquatic environments (1). NCLDVs include Poxviridae, Asfarviridae, 43 
Iridoviridae, Ascoviridae, Phycodnaviridae, Mimiviridae, and Marseilleviridae (2). The 44 
Paramecium bursaria chlorella virus PBCV-1 was the first large DNA virus characterized at 45 
the molecular level and shown to harbor a complex genome of 330 kbp (3). But the largest 46 
NCLDVs described to date belong to Mimiviridae, which occur in fresh and saline 47 
environments and replicate within amoebae (4).  Acanthamoeba polyphaga mimivirus was 48 
the first Mimiviridae isolated from a cooling water tower and characterized in 2003 (5).  49 
Other members of Mimiviridae include megavirus isolated from a marine environment (6),  50 
mamavirus (7), and moumouvirus (8). Mimiviridae feature large capsids exceeding 400 nm 51 
diameter and harbor large genomes of more than 1 Mbp. The genomes of NCLDVs encode 52 
structural proteins and enzymes usually not found in viruses, such as aminoacyl-tRNA 53 
synthetases, DNA repair enzymes, potassium ion channel, protein kinases and 54 
glycosyltransferases (5, 9, 10). 55 
Interestingly, Mimiviridae also express multiple collagen genes during their infectious life 56 
cycle in amoebae. For example, mimivirus expresses seven collagen genes, namely L71, 57 
R196, R239, R240, R241, L668, L669, already by 6 h post infection (11). Even the virophage 58 
Sputnik includes two collagen genes among its predicted 21 open reading frames (12). The 59 
functional relevance of these collagens is however presently unknown. First analysis of 60 
mimivirus proteins indicated that collagen is hydroxylated like animal collagen (13).  Cryo-61 
electron microscopy and atomic force microscopy studies failed to reveal any collagen-like 62 
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structures in mimivirus (14, 15), although the dense fibers surrounding mimivirus capsids 63 
have been suggested to represent cross-linked glycosylated collagen (14). 64 
The ubiquitous distribution of NCLDVs in aquatic environments (16, 17) suggests that 65 
humans are constantly exposed to such viruses. Mimivirus cannot replicate in animal cells 66 
but can be internalized by phagocytosis by mouse and human macrophages (18). The uptake 67 
of mimivirus particles by human macrophages potentially leads to virus antigen 68 
presentation and thereby to the generation of antibodies against virus proteins. Considering 69 
the structural similarity between animal and Mimiviridae collagens, we made the hypothesis 70 
that antibodies generated against Mimiviridae collagens may cross-react with animal 71 
collagens and thereby contribute to an autoimmune response to collagenous structures in 72 
animals previously exposed to Mimiviridae. The present study provides evidence supporting 73 
this hypothesis, showing that arthritis can be triggered in mice immunized with mimivirus 74 
particles and by unraveling increased occurrence of antibodies against mimivirus collagen 75 
in rheumatoid arthritis patients.   76 
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Materials and Methods 77 
Ethics Statement - All mouse experiments were performed in compliance with the Swiss 78 
Animal Protection Ordinance and approved by the local veterinary authority (Kantonales 79 
Veterinäramt Zürich, Switzerland). The human sera tested in this study were a part of 80 
previously existing collection and the experimental protocol approved by the Kantonale 81 
Ethik-Kommission Zürich (KEK). 82 
 83 
Giant virus infection and protein extraction - Acanthamoeba polyphaga and mimivirus 84 
were provided by Didier Raoult (CNRS UMR6020, Université de la Méditerranée, Marseille). 85 
Marseillevirus (2) was isolated from a water sample collected from the Lake of Zurich. 86 
Amoebae were routinely cultured as monolayer in PYG medium at 28°C as previously 87 
described (5). Mimivirus and marseillevirus were added to multiplicity MOI 10 to amoebae 88 
and newly formed virus were collected from the culture supernatant 2 days post infection. 89 
Virus particles were suspended in 0.5 M Tris-HCl, pH 8.5, 0.2% CHAPS, 2 mM TCEP, 6 M 90 
guanidine hydrochloride and incubated at 65°C for 10 min. After cooling to room 91 
temperature, iodoacetamide was added to a final concentration of 3 mM and further 92 
incubated at room temperature for 40 min. After adding DTT to a final concentration of 15 93 
mM, protein extracts were centrifuged at room temperature at 17,000 x g and proteins in the 94 
supernatant were precipitated with 12% trichloroacetic acid. 95 
 96 
Surface biotinylation of mimivirus proteins - Purified mimivirus particles were 97 
suspended in PBS and sulfo-NHS-biotin (Thermo Scientific, Waltham, MA, USA) was added 98 
to a final concentration of 1 mg/ml. Virions were rotated for 30 min at room temperature 99 
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and the reaction was quenched by adding equal volume of 100 mM glycine in PBS. Virions 100 
were pelleted and washed twice with 100 mM glycine in PBS and proteins were extracted 101 
with guanidine hydrochloride as described above. Extracts were diluted 10-fold in PBS, 0.1 102 
% CHAPS, containing proteinase inhibitors (Calbiochem Proteinase Inhibitor Cocktail III, 103 
Merck Millipore, USA) and subjected to avidin cartridge purification (ABSciex, Framingham, 104 
Massachusetts, USA). The cartridge was successively washed with 500 µl PBS, 0.1% CHAPS; 105 
1 ml of 650 mM NaCl in 20 mM phosphate buffer pH 7.2, 0.1% CHAPS; 1 ml of PBS, 0.1% 106 
CHAPS and 1 ml of 0.1% CHAPS in H2O, and biotinylated proteins were eluted with 800 µl 107 
0.4% trifluoroacetic acid, 0.1% CHAPS. Proteins were precipitated with trichloroacetic acid 108 
and subjected to SDS-PAGE. Individual protein bands were excised and subjected to in-gel 109 
tryptic digestion, as previously described (19, 20) followed by LC-MS protein identification. 110 
LC-MS data were analyzed using Mascot (Matrix Science, London, UK; version 2.3.02). Mascot 111 
was set up to search a Swissprot concatenated target-decoy database (2011.01.11, 1049100 112 
entries) assuming the digestion enzyme trypsin. Mascot was searched with a fragment ion 113 
mass tolerance of 0.60 Da and a parent ion tolerance of 10.0 PPM. Iodoacetamide derivative 114 
of cysteine was specified in Mascot as a fixed modification. Oxidation of methionine and 115 
biotinylation of lysine were specified in Mascot as variable modifications. Scaffold (version 116 
Scaffold_3.4.9, Proteome Software Inc., Portland, OR, USA) was used to statistically validate 117 
MS/MS based peptide and protein identifications. 118 
 119 
Collagen induced arthritis model - DBA/1 mice were purchased from Charles River 120 
(Germany), bred and maintained in the animal facility of Institute of Physiology, University 121 
of Zurich. All experiments were performed in compliance with the Swiss Animal Protection 122 
7 
 
Ordinance and approved by the local veterinary authority (Kantonales Veterinäramt Zürich, 123 
Switzerland). Collagen induced arthritis was established as described before (21). Briefly, 6-124 
8 week old mice were immunized intra-dermally in the tail either with PBS, bovine collagen 125 
type II (Chondrex, USA), mimivirus L71 collagen-like protein, mimivirus protein extract, or 126 
marseillevirus protein extract emulsified in Complete Freund’s Adjuvant (CFA, Chondrex, 127 
USA). Each mouse received either 50 µl of PBS, 100-120 µg of bovine collagen type II, 150 µg 128 
of recombinant L71 collagen-like protein, 120-150 µg of mimivirus proteins, or 120-150 µg 129 
of marseillevirus proteins emulsified 1:1 in CFA in a total volume of 50 µl. Mice received 30 130 
days later a booster injection of the same amount of antigen emulsified 1:1 in Incomplete 131 
Freund’s Adjuvant (IFA, Chondrex, USA).  Development of arthritis was monitored daily for 132 
75 days post immunization. Severity was scored on a level of 0 (no inflammation) to 4 (most 133 
severe inflammation) per limb per mouse, thus allowing a maximum score of 16 per mouse 134 
(21). 135 
 136 
Anti-collagen type II antibodies - Mouse blood sera were collected by heart puncture. Anti-137 
mouse CII antibody titers were measured in blood sera by ELISA (Chondrex, USA) as per 138 
manufacturer’s instructions.  139 
 140 
Histology – Limbs were skinned and fixed overnight in 10% neutral buffered formalin. 141 
Tissues were further decalcified using Immunocal solution (Quartett, Germany) for 4-5 days, 142 
dehydrated and paraffin embedded.  Sections of 5 µm were mounted on glass slides and 143 
stained with H&E.  144 
 145 
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Recall assay - Axillary, lateral axillary, superficial inguinal and popliteal lymph nodes from 146 
mice were collected 8-10 days post booster immunization. Aliquots of 100,000 cells in 100 147 
µl complete RPMI-1640 medium were stimulated with antigens and incubated for 48 h in a 148 
CO2 incubator at 37°C with 5% CO2.  Cells were stimulated in 100 µl either with medium 149 
alone as negative control or concanavalin-A (Sigma, Switzerland) at 3 µg/ml as positive 150 
control. T-cell proliferation grade denatured mouse collagen type II at 1 mg/ml (Chondrex, 151 
USA), T-cell proliferation grade denatured bovine collagen type II at 1 mg/ml (Chondrex, 152 
USA) and heat denatured mimivirus collagen L71 at 1.5 mg/ml were used as antigen. After 153 
48 h, 1 µCi of [3H]thymidine (Perkin-Elmer, USA) per well was added, incubated for 16-18 h 154 
and cells were harvested on 96-well glass filter (Perkin-Elmer, USA). Radioactivity was 155 
counted using a 96-well scintillation beta-counter (Wallac, Perkin-Elmer). 156 
 157 
Anti-mimivirus ELISA - Mimivirus proteins were coated in microtiter plates at 0.1 µg per 158 
well in 100 µl PBS overnight at 4°C. Plates were washed thrice with PBS-0.05% Tween and 159 
blocked with PBS, 0.05% Tween, 1% bovine serum albumin at 37°C for 2 h. Plates were 160 
washed,  100 µl of diluted human and rabbit sera added and further incubated at room 161 
temperature for 1 h. After three wash steps, 100 µl of 1:5000-diluted biotinylated anti-162 
human or anti-rabbit IgG antibody (BD Biosciences, Switzerland) were added for 2 h. Plates 163 
were washed and 100 µl of 1:1000-diluted streptavidin-HRP conjugate (BD Biosciences) 164 
added for 1 h in dark. Plates were washed, incubated for 2 min with 50 µl 3, 3’ , 5, 5’ 165 
tetramethylbenzidine (TMB) substrate (BD Biosciences) before stopping the reaction with 166 
25 µl of 2 N H2SO4. Color development was measured at 440 nm. 167 
 168 
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Immunoprecipitation of mimivirus proteins – Aliquots of 25 µl of human sera were 169 
incubated with 30 µl of protein-G sepharose 4 Fast Flow (GE Healthcare, Switzerland) beads 170 
along with 80 µl PBS on a rotating shaker for 1 h at 4°C. After centrifugation at 500 x g for 5 171 
min at 4°C, supernatants were discarded and beads incubated with 20 µg of mimivirus 172 
protein extract in 80 µl of PBS and further incubated on a rotating shaker for 30 min at 4°C. 173 
Beads were washed three times in PBS and antigen-antibody complexes were eluted from 174 
the beads by adding 40 µl of 0.1 M glycine, pH 2.7. After neutralization by addition of 20 µl of 175 
1 M Tris-HCl pH 9, eluates were separated by SDS-PAGE. Slices of polyacrylamide gel 176 
excluding IgG chains were excised and subjected to in-gel tryptic digest as previously 177 
described (20) and peptides identified by tandem mass spectrometry as above.  178 
 179 
Cloning, bacterial expression and purification – The mimivirus ORF L71 and L425 were 180 
custom synthesized (Genescipt, USA) and subcloned into the expression vector pET16b 181 
(Merck Millipore, Switzerland) linearized with XhoI and HindIII (for L71) or XhoI and BamHI 182 
(for L425). His6-tagged recombinant proteins were expressed after transformation into E. 183 
coli BL21 (DE3) cells (Novagen, Switzerland) under induction of 0.2 mM IPTG at 32°C for 1.5 184 
h. Recombinant proteins were purified over Ni-Sepharose 6 Fast Flow (GE Healthcare, 185 
Switzerland) gravity flow columns.  186 
 187 
Western blotting – Aliquots of 15 µg of recombinant mimivirus L71 and L425 proteins were 188 
subjected to SDS-PAGE and transferred to PVDF membrane (Bio-Rad). A His6-tagged 15 kDa 189 
fragment of the human GLT25D2 protein (22) was used as negative control.  A 36 kDa His6-190 
tagged fragment of human collagen type III encompassing 114 [G-X-Y] repeats and lacking 191 
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N- and C-propeptides was provided by Christoph Rutschmann, Institute of Physiology, 192 
University of Zurich. Blots were blocked in 1% polyvinylpyrrolidone (Sigma, Switzerland) + 193 
5% dry milk solution overnight at 4°C, then washed three times for 5 min with TBS, 0.1% 194 
Tween and incubated with human sera diluted 1:4000 for 2 h at room temperature. After 195 
washing four times for 5 min, blots were incubated with anti-human IgG-HRP (Promega, 196 
Switzerland) at 1:7500 dilution at room temperature for 1 h. Blots were developed with 197 
SuperSignal chemiluminescent substrate (Thermo Scientific). 198 
 199 
Statistical analysis - One way ANOVA with Dunnett’s multiple comparison (GraphPad 200 
Prism) was performed to compare experimental groups.  201 
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Results 202 
Surface localization of mimivirus collagen 203 
To assess the possible localization of collagens at the surface of mimivirus, we have applied 204 
a biotinylation approach on mimivirus particles. Biotinylated mimivirus proteins were 205 
captured on streptavidin beads, eluted and identified by tandem mass spectrometry, which 206 
revealed 60 surface proteins including the collagen protein L71 (Table 1). The L71 protein 207 
has 945 amino acids with 4 collagen domains encompassing 561 amino acids (Fig. 1). The 208 
first collagenous domain of L71 includes a stretch with 73% sequence identity to a major 209 
human collagen type II T-cell epitope identified in rheumatoid arthritis (23, 24).  Other 210 
identified surface proteins comprised the capsid protein L425, the putative GMC-type 211 
oxidoreductase R135, the thioredoxin domain-containing protein R362 among several 212 
uncharacterized proteins (Table 1). 213 
Mimivirus proteins promotes arthritis in mice 214 
Considering the surface expression of collagen L71, we have addressed the potential of 215 
mimivirus and recombinant L71 protein to induce joint inflammation in DBA/1 mice using 216 
the standard protocol for collagen-induced arthritis (21), which closely resembles 217 
rheumatoid arthritis in humans. Bovine collagen type II was used as positive control to 218 
induce arthritis. A protein extract of the giant virus marseillevirus, which lacks collagen-like 219 
proteins, was used as negative control. Intradermal immunization of bovine collagen type II 220 
and mimivirus protein extracts lead to joint inflammation as assessed by visual inspection 221 
and histological examination of limb tissues. Mice immunized with mimivirus proteins 222 
reached clinical scores of 6 whereas those immunized with bovine collagen type II reached 223 
12 by 75 days (Fig. 2A). By contrast, immunization with recombinant L71 protein alone and 224 
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immunization with marseillevirus proteins failed to elicit joint inflammation (Fig. 2A). 225 
Altered cartilage integrity and synovial hyperplasia were evident in joints of mice 226 
immunized with bovine collagen type II and to a lesser extent in mice immunized with 227 
mimivirus proteins (Fig. 2B).  228 
The breakage of immune tolerance induced by bovine collagen and mimivirus proteins was 229 
confirmed by detecting elevated serum titers of anti-mouse collagen type II IgG in mice 230 
immunized with bovine collagen type II and mimivirus proteins, whereas mice immunized 231 
with PBS and marseillevirus did not show elevated anti-mouse collagen type II IgG titers   232 
(Fig. 3). Mice immunized with recombinant L71 protein also showed significantly elevated 233 
anti-mouse collagen type II IgG titers, yet by an order of magnitude lower than the titers 234 
observed in mice immunized with mimivirus proteins (Fig. 3). The lower antibody response 235 
achieved with L71 immunization may account for the lack of joint inflammation seen in these 236 
mice. The cross-reactivity of T-cells was investigated in recall assays (25). Cells isolated from 237 
draining lymph nodes of the immunized mice were found to proliferate in response to in 238 
vitro presentation of denatured fragments of mouse collagen type II (Fig. 4A), bovine 239 
collagen type II (Fig. 4B), and mimivirus collagen protein L71 (Fig. 4C), thereby confirming 240 
the presence of auto-reactive T-cells after immunization with mimivirus proteins. The 241 
proliferative response to collagen was strongest for cells isolated from mice immunized with 242 
mimivirus proteins. This finding was surprising since mice immunized with bovine collagen 243 
type II showed the highest score for limb inflammation and for anti-collagen IgG titers. The 244 
strong proliferative response of T-cells from mimivirus proteins-immunized mice may 245 
reflect the higher antigenicity of mimivirus collagen considering its peptide sequence 246 
divergence from mammalian collagen sequences. 247 
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Immunity to mimivirus in humans 248 
To determine whether humans are commonly exposed to mimivirus, we first examined the 249 
presence of antibodies against mimivirus in 100 healthy subjects by ELISA using whole 250 
mimivirus proteins as antigens. Reactivity to mimivirus proteins was variable; 58 human 251 
sera showed significant IgG titers in the 5% range of titers observed in the sera of rabbits 252 
previously immunized with mimivirus proteins (Fig. 5). To identify the major mimivirus 253 
proteins recognized by human sera, we coupled the IgG fraction of sera from healthy subjects 254 
and rheumatoid arthritis patients to protein-G sepharose beads, which were further 255 
incubated with preparations of mimivirus proteins. Mimivirus proteins retained on the IgG-256 
protein G beads were identified by mass spectrometric peptide sequencing after trypsin 257 
digestion. The major capsid protein L425 was found in all samples followed by the putative 258 
GMC type oxidoreductase R135 and core protein L410, which were found in seven from ten 259 
samples (Table 2). Interestingly, the most frequent mimivirus proteins recognized by human 260 
sera were surface proteins according to our surface biotinylation study (Table 1). Mimivirus 261 
collagens did not appear among the proteins recognized by sera. This absence may be related 262 
to the abundance of lysine in mimivirus collagens, thereby yielding very short tryptic 263 
peptides that remained below the detection range of mass spectrometric peptide 264 
sequencing. The recognition of multiple mimivirus proteins by human sera confirmed the 265 
exposure of humans to mimivirus. 266 
To further validate the occurrence of antibodies against specific mimivirus proteins in 267 
human sera were analyzed by Western blot. The major capsid L425 and collagen L71 268 
proteins were expressed as His6-tagged recombinant proteins in E. coli and purified on Ni2+-269 
sepharose columns. Pools of 100 healthy subject sera and 100 rheumatoid arthritis sera 270 
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were probed against the recombinant L425 and L71 mimivirus proteins. We examined the 271 
reactivity of sera towards surface collagen L71 since this protein was not detected among 272 
the mimivirus proteins captured by immobilized serum IgG in our previous experiment. For 273 
the 100 healthy subject and 100 rheumatoid arthritis sera tested, respectively 30 and 36 sera 274 
recognized the capsid L425 protein (Fig. 6A). This results confirmed that exposure to 275 
mimivirus is common in the human population. The detection of IgG against the mimivirus 276 
capsid protein L425 in 30% of tested sera suggests repeated antigenic challenge probably 277 
caused by repeated contact with mimivirus. Reactivity of human sera towards mimivirus 278 
collagen was more discriminatory. Whereas only 6 healthy subject sera recognized the 279 
mimivirus collagen L71, 22 rheumatoid arthritis sera were positive for the mimivirus 280 
collagen L71 (Fig. 6B). To exclude unspecific cross-reactivity of human sera towards 281 
polypeptides containing [G-X-Y]n collagen domains, we have tested the recognition of L71-282 
positive   sera for a fragment of human collagen type III encompassing 114 [G-X-Y] repeats 283 
and lacking N- and C-propeptides. None of the 28 human sera positive for mimivirus L71 did 284 
recognize the 36 kDa [G-X-Y]114 construct (Fig. 7), thereby demonstrating the specificity of 285 
the antibody response to mimivirus L71 collagen. Accordingly, this work confirmed that the 286 
reactivity to mimivirus collagen was 3.5 times more frequent in the pool of rheumatoid 287 
arthritis sera in comparison to the limited reactivity of sera from healthy subjects.   288 
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Discussion 289 
The present study demonstrated that mice generated auto-reactive anti-collagen antibodies 290 
after immunization with mimivirus proteins including viral collagens. A possible 291 
relationship between exposure to mimivirus collagen and the development of auto-292 
immunity was corroborated by the occurrence of IgG against mimivirus collagen among 293 
rheumatoid arthritis patients. These findings suggested that repeated exposure to mimivirus 294 
leads to antibody formation to virus collagen and to a breakage of immune tolerance for 295 
endogenous collagens. Giant viruses like mimivirus are ubiquitous in the environment (16, 296 
17), thereby supporting the frequent contact of humans to such viruses. Mimivirus is most 297 
likely ingested by water uptake and captured by dendritic cells and macrophages lining the 298 
gastrointestinal mucosa. Alternatively, virus particles may enter the airways as aerosol and 299 
be taken up by alveolar macrophages. In fact, mimivirus can be phagocytized by human and 300 
mouse macrophages although the virus cannot replicate in these cells (18). Along this line, 301 
mimivirus infection has been related to pneumonia in isolated cases, although without 302 
evidence for virus particles in disease cases (26, 27). This putative pathogenicity however 303 
does not preclude a more general effect of mimivirus on priming an auto-immune response. 304 
The sequence similarity between a stretch of mimivirus L71 and human collagen type II (Fig. 305 
1) supports a possible cross-reactivity of antibodies due to antigenic mimicry. This was 306 
indeed confirmed in our study by the detection of anti-mouse collagen type II IgG in mice 307 
immunized with recombinant L71 protein. A similar case of antigenic mimicry occurs in 308 
Campylobacter jejuni infection, which causes gastroenteritis, but can lead to Guillain-Barré 309 
syndrome when antibodies against Campylobacter lipooligosaccharides cross-react with 310 
endogenous GM1 gangliosides on nerves cells (28). Likewise, the detection of antibodies 311 
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towards mimivirus L425 capsid protein in some Francisella tularensis infected patients 312 
suggested cross-reactivity of mimivirus antigens with other microorganisms (29). But 313 
surprisingly, no reactivity to mimivirus antigens was found in sera from healthy subjects in 314 
the study of Pelletier et al. (29). 315 
The main factors involved in the pathogenicity of rheumatoid arthritis could either be 316 
genetic or environmental factors. Rheumatoid arthritis is an autoimmune disease with a 317 
significant environmental component as supported by twin studies (30, 31). Repeated 318 
contact to collagen antigens found in the environment may promote the development of 319 
cross-reactive anti-collagen antibodies and to inflammation in collagen-rich tissues. 320 
Antibodies against collagens can either recognize the triple helical conformation, or peptides 321 
sequences in the triple helical domain or in telopeptides. The specificity of antibodies against 322 
collagen depends on the activation of a humoral response alone, or on a combination of cell-323 
mediated and humoral responses (32). The reactivity of human sera to mimivirus collagen 324 
L71 shown by Western blotting indicates that epitopes based on amino acid sequence and 325 
not 3D conformations are being recognized. This notion was supported by finding no 326 
reactivity of the L71-positive human sera for the human collagen type III [G-X-Y]114 327 
polypeptide used as negative control. The lack of recognition for the [G-X-Y]114 polypeptide 328 
also indicated that the reactivity towards L71 was specific to mimivirus exposure and not 329 
the result of cross-reactivity to collagen-domain containing proteins such as those found in 330 
some Gram-positive bacteria. We did find that mimivirus L71 protein was immunogenic and 331 
lead to the production of anti-mouse collagen type II IgG, but immunization of DBA/1 mice 332 
with recombinant L71 protein failed to induce arthritis. This recombinant protein likely did 333 
not mimic the native conformation of collagen-like proteins, which is essential for 334 
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arthritogenicity. In fact, denaturation of collagen prior to immunization abrogates the 335 
arthritic response (33). 336 
Altogether, in view of the structural similarity between mimivirus collagen and human 337 
collagen sequences, we propose that giant viruses expressing collagen represent a potential 338 
environmental risk factor contributing to the development of rheumatoid arthritis. A 339 
systematic survey of mimivirus distribution in the environment will contribute to a better 340 
appreciation of the environmental risk associated to such giant viruses in relation to the 341 
geographical incidence of rheumatoid arthritis.  342 
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Table 1. Mimivirus surface proteins identified by biotinylation. 451 
ORF Protein annotation % coverage 
R459 Uncharacterized protein 92% 
L724 Uncharacterized protein 69% 
L725 Uncharacterized protein 51% 
R489 Uncharacterized protein 49% 
R714 Uncharacterized protein 42% 
L485 Uncharacterized protein 41% 
L330 Uncharacterized protein 36% 
R305 Uncharacterized protein 36% 
R727 Uncharacterized protein 35% 
R345 Uncharacterized protein 35% 
L53 Uncharacterized protein 33% 
R457 Uncharacterized protein 33% 
R362 Thioredoxin domain-containing protein 26% 
L488 Uncharacterized protein 24% 
R346 Uncharacterized protein 24% 
L586 Uncharacterized protein 23% 
L829 Uncharacterized protein 23% 
R623 Uncharacterized protein 22% 
L550 Uncharacterized protein 22% 
L425 Capsid protein-1 19% 
L647 Uncharacterized protein 19% 
R306 Uncharacterized protein 19% 
L645 Uncharacterized protein 19% 
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L591 Uncharacterized protein 19% 
L719 Uncharacterized protein 18% 
R463 Uncharacterized protein 18% 
R705 Uncharacterized protein 17% 
L585 Uncharacterized protein 17% 
L454 Uncharacterized protein 17% 
R653 Uncharacterized protein 16% 
R610 Uncharacterized protein 14% 
L629 Uncharacterized protein 14% 
R710 Uncharacterized protein 13% 
L399 Uncharacterized protein 12% 
R443 Thioredoxin domain-containing protein 12% 
R253 Uncharacterized protein 11% 
L324 Uncharacterized protein 11% 
R307 PP2C-like domain-containing protein 11% 
L492 Uncharacterized protein 11% 
R596 Probable FAD-linked sulfhydryl oxidase 10% 
R135 Putative GMC-type oxido reductase 9.5% 
L442 Uncharacterized protein 9.5% 
R347 Uncharacterized protein 9.5% 
R622 Putative tyrosine-protein phosphatase 9% 
L609 Uncharacterized protein 8.6% 
L612 Uncharacterized protein 7.5% 
L309 Uncharacterized protein 6.2% 
R252 Uncharacterized protein 6.1% 
R526 Putative alpha/beta hydrolase 6.1% 
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R692 Uncharacterized protein 4.8% 
L236 Uncharacterized protein 4.7% 
L448 Uncharacterized protein 4.5% 
L264 Uncharacterized WD repeat-containing protein 4.5% 
R588 Uncharacterized protein 3.3% 
L605 Structural PPIase-like protein 3% 
R553 Uncharacterized protein 2.7% 
L71 Collagen-like protein 1 2.5% 
L357 Uncharacterized protein 2.4% 
R643 Uncharacterized protein 2.2% 
L397 Uncharacterized protein 2.1% 
Mimivirus surface proteins identified by mass spectrometric peptide sequencing after biotinylation 452 
and analyzed by Mascot software. Results were validated by Scaffold (version Scaffold_3.4.9, 453 
Proteome Software Inc., Portland, OR) and peptide identifications were accepted if they established 454 
>80% probability as specified by the Peptide Prophet algorithm (34).  Protein identifications were 455 
accepted if they could be established at >99% probability and contained at least 2 identified peptides 456 
as specified by Protein Prophet algorithm (35).  457 
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Table 2. Mimivirus proteins recognized by human serum IgG 459 
ORF Protein annotation Healthy subjects Rheumatoid Arthritis 
L425 Capsid protein 68 601 463 68 387 983 271 258 70 327 
R135 Putative GMC-type oxidoreducatse  370 394  153 774 255 163  161 
L410 Core protein  223 284  179 685 123 133  97 
R345 
Putative regulator of chromosome 
condensation 
52 123 145 28 58 350 185 77  217 
R349 Uncharacterized protein 28 28 30 26 26 35 26  28 32 
Scores for viral proteins recognized by 5 healthy subject sera and 5 rheumatoid arthritis sera 460 
are listed in columns for each serum tested. Values indicate Mascot scores representing the 461 
probability of positive matches for the recognized proteins. Scores above 25 were significant 462 
for p<0.05. 463 
N C44 63 69 111 945
Hu CII259-273:  GIAGFKGEQGPKGEP
Mi L71101-115:  GEAGLKGEQGTKGEQ
*
*
Figure 1. Domain organization of mimivirus L71 protein. The four collagen domains of
L71 are shown as grey boxes with the number of G‐X‐Y repeats given inside. The asterisk
shows the position of the sequence motif similar to the epitope human collagen type II
recognized as immunodominant in rheumatoid arthritis [24]. The sequence of this human
collagen type II (Hu CII) T‐cell epitope encompassing amino acids 259‐273 is shown aligned
with the corresponding sequence of mimivirus L71 (Mi L71) encompassing amino acids
101‐115.
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Figure 2. Joint inflammation in DBA/1 mice immunized with mimivirus proteins. (A) Clinical
severity of arthritic limbs in the groups of PBS (), bovine collagen type II (), recombinant L71
protein (), marseillevirus proteins () and mimivirus proteins () immunized mice are shown as
mean ± SEM. The arrow shows the time point of booster immunization. Data represent three
independent experiments including 10‐21 mice per group. (B) Representative H&E stained sections of
hind limbs by day 75 after immunization showing cartilage damage and synovial hyperplasia in bovine
collagen type II (BovCII) and mimivirus protein (MV) immunized mice. No sign of pathology were
visible in PBS negative control mice (Neg), scale bar 100 µm.
Figure 3. Anti‐collagen type II IgG titers in DBA/1 mice immunized with mimivirus
proteins. Levels of serum IgG measured by ELISA against endogenous mouse collagen type
II (CII) in mice immunized with PBS (Neg), bovine collagen type II (BovCII), mimivirus
proteins (MV), marseillevirus proteins (MsV), or recombinant L71 protein (L71). Data
represent three independent experiments including 10‐21 mice per group, horizontal bars
show mean ±SEM, *p<0.01.
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Figure 4. Auto‐reactive T‐cell response in DBA/1 mice immunized with mimivirus
proteins. (A) Recall responses in cells isolated from draining lymph nodes from mice
immunized with PBS (Neg), bovine collagen type II (BovCII), or mimivirus proteins (MV)
after stimulation with denatured mouse collagen type II. (B) Recall responses after
stimulation with denatured bovine collagen type II. (C) Recall responses after stimulation
with denatured fragmented recombinant mimivirus protein L71. Data represent mean ±
SEM from groups of 3 mice, *p<0.01.
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Figure 5. Reactivity of human sera towards mimivirus proteins. Anti‐mimivirus IgG
titers in sera of 100 healthy subjects were measured by ELISA after dilution 1:100 and
expressed as a ratio to IgG titers measured in 1:1000‐diluted sera from rabbits previously
immunized with mimivirus particles. Data represent mean ± SEM from 4 analyses.
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Figure 6. Recognition of mimivirus proteins by human sera. (A) Representative
Western blots of sera from healthy subjects (HS) and rheumatoid arthritis (RA) patients
recognizing mimivirus capsid protein L425. (B) Representative Western blots of sera from
healthy subjects (HS) and rheumatoid arthritis (RA) patients recognizing mimivirus
collagen L71. Sera were diluted 1:4000. Positions of recombinant L425 and L71 proteins in
the blots are shown at the left of each panel using an anti-His6 antibody (His6). A 15 kDa
fragment of His6-tagged human GLT25D2 protein was used as negative control (Neg).
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Figure 7. Specific recognition of mimivirus collagen L71 by human sera.
Representative Western blots of L71-positive sera from healthy subjects (HS) and
rheumatoid arthritis (RA) patients recognizing mimivirus collagen L71 but not a
fragment of human collagen type III containing 114 [G-X-Y] repeats (CIII). Sera were
diluted 1:4000. Positions of recombinant L71 and CIII proteins in the blots are
shown at the left of the panel using an anti-His6 antibody (His6).
